ALKS failed Phase 2 not sufficient enough for a phase 3! not looking good !
Why the concern?? They just arent going to spend a lot of money on R & D, when its not warrented!! They have the right to outsource this drug to another biotech, if someone wants to take up the chase. I think it was a wise decision!!